Doctor Writes About Fighting Brain Cancer

March 27, 2007 — -- Dr. Bernadine Healy is perhaps best known for leading some of the largest, most respected medical institutions in the country. But on Valentine's Day 1999, she was dealt a blow that shattered her world.

That was the night when Healy found out that she had brain cancer. Doctors gave her three months live without treatment. With chemotherapy, her chances increased to 18 months to two years.

But eight years later, Healy is still thriving. Her book, "Living Time," is written from two perspectives -- that of the physician and that of the patient -- about her fight against brain cancer. She hopes it will help people diagnosed with the disease to realize that cancer isn't "dying time" -- it's "living time."

Read an excerpt from "Living Time" below:

Chapter One

A Valentine's Day

SO THIS IS HOW I DIE.

These words ran through my mind as I lay in the emergency room of the Cleveland Clinic on Valentine's Day, 1999. It was in the wee hours of the morning, a time I remembered all too well from my medical residency years at Johns Hopkins. That's when the ER would fill up with drunks and drug addicts, knife and gunshot casualties, car accident survivors, and early morning heart attack victims. Many years had passed since then, but now I was one of them, an emergency room patient in great distress. I had just received startling information that would forever change my life.

Only a few hours earlier, my husband, Fred, and I were sitting up in bed watching the Oscar De La Hoya fight on HBO. At some point that I cannot recall, I passed out, only to awaken with the local rescue squad standing by our bed. I was confused. Why were they talking to Fred about my ambulance ride to the hospital? Why was my husband on the phone with his good friend Al Lerner, asking him to meet us in the emergency room? I protested that this was all unnecessary, that I felt entirely well. I had an overwhelming desire to stay and comfort our terrified twelve-year-old, Marie, trembling in the shadows, and to talk to Michele, my sister, who'd rushed over to be with her. Despite these protests, I soon found myself strapped to a narrow gurney in an ambulance with flashing lights, hurtling along dark, deserted streets into midtown Cleveland.

Dr. Patrick Sweeney, the gentle, white-haired neurologist who was the attending physician that evening, met us in the ER, ready to perform the usual neurological tests for what my husband believed had been a seizure. Fred is a renowned cardiac surgeon and at the time was the director of the Cleveland Clinic, but he was pure husband that night. He listened attentively to Dr. Sweeney and acted as the best of spouses would, making sure I was comfortable, squeezing my hand, and calming my nerves with lighthearted jokes: "Hey, was this just your way of getting out of watching the prizefight?"

But very shortly we found that my blackout had not been an inconsequential seizure after all. Fred knew first because he went off to huddle with the radiologist to review the brain scans. He stood quietly by, eyes swollen, as Dr. Sweeney brought me the shocking news: the spell had resulted from a good-sized tumor growing in the left side of my brain. I asked Dr. Sweeney if it was malignant. Leaning over the rail, peering into my eyes, he said simply, "Yes."

Even though Fred and I have an uncanny ability to think the same thoughts at the same time, this was one moment when we could not bear to share those thoughts. After all, we always said we were goose and gander, mated for life; we wouldn't do well without each other. And all I could think was: So this is how I die. Not in a car accident or a plane crash, not felled by a heart attack in honor of my own medical specialty. It would be by my own cells, mutating and roaming inside my body -- in my head, no less. I felt powerless and immobile. My own life's work with the critically ill brought me no special strength or solace; if anything, I knew too much. This cancer was insidious, already having grown to a near-fatal state in my brain without ever tipping me off. Not one hint.

Here I was in the prime of life, and fairly diligent about all the healthy habits I had preached so reverently for decades. Though a cardiologist by training, I had also earned my stripes in the war on cancer: I was then the dean of the College of Medicine and Public Health at Ohio State University, where I had been expanding the school's cancer genetics program. Years before, I had headed the Research Institute of the Cleveland Clinic Foundation, where I built its first cancer biology department. And as director of the National Institutes of Health in the early 1990s, I oversaw the National Cancer Institute and participated in its 1991 celebration of twenty years of the National Cancer Act, which brought us the war on cancer. There I also immersed myself in the massive effort to unravel the human genome, which will have its greatest payoff in the area of cancer. And in the course of my life as a hands-on physician, I had cared for and consulted with patients who had had a brain tumor. I had every reason to know the meaning of my newly diagnosed illness. It was not good.

At that long moment of discovery, looking up into the sad, drawn face of my husband, I knew that all of our medical expertise combined would not help us cope with this numbing news. No matter who we are, from whatever background, we all feel the same chill upon hearing the C word. It's a universal fact: when serious illness strikes, we are the same vulnerable souls.

And so are our families. Returning home the next day, that became all too evident. Their world, too, suddenly becomes cloudy. It was hard to explain to those on the home front what still seemed inexplicable to us. To my ninety-eight-year-old mother-in-law, Nonie, who lived with us, this was bewildering news. Her "Bernie dear" was never sick. As for my mom, cancer was the thief that had taken my dad from us twenty years before, and it was not hard to see in her pale, stoic face that she knew what might be in store. How good it was that she had moved right next door to us several years before -- although the plan then was that we could look after her, not the opposite. Things also changed for my sister Michele, who was part of our family compound, too. Her protective big sister was suddenly the weaker one. My heart swelled with gratitude when she whispered in my ear that if it was needed, she was ready to offer up her bone marrow or anything else she could to get me through this. But what proved hardest for me were those lingering hugs from my two girls, twelve-year-old Marie, who had been up all night, and nineteen-year-old Bartlett, who rushed home from college. Moms are supposed to be there when you're growing up, after all, and the sinking feeling that it might not happen for them was obviously written all over my face. As I surveyed my treasured nest, I knew that this illness was not only about me. I had just managed to rock my family's universe, and it was going to be my job to keep that in mind as I navigated this journey.

I recollect this traumatic time not to torment myself or to unsettle you, but because I have come to understand that in slogging through the dark valley of cancer I experienced another dimension of life. Confronting and surviving this disease compelled me to do a mitzvah, a good deed, in the only way I know how -- by writing this book. As a physician who has cared for the seriously ill and spent a lifetime immersed in almost every dimension of health and disease, I was now the vulnerable patient. Through it all I've acquired some hard-won insights that just might help others facing a similar predicament -- insights that I so dearly would have valued but were not clearly evident to me at the time. And they came not because I had a unique experience that turned out better than expected, but rather because I lived an all-too-common one. Only in retrospect can I see that my illness turned out probably as it should have, but not as well as it will in the future for others who will have the means to find it sooner and extinguish it faster. The common denominator for us all, in the still early morning of this new century, is that we are witness to a mighty sea change in the life of medicine and its war on cancer.

But back to the home front. My husband got the wheels in motion. He arranged for the surgery that would be performed a few days later by Gene Barnett, his colleague and director of the Cleveland Clinic's Brain Tumor and Neuro-Oncology Center. Dr. Barnett would remove as much of the tumor as he could. With tissue in hand we would nail down precisely what variety of tumor showed up as a nasty white blotch on my scans and map out the next steps. Though he did not spell it out to me in such detail at the time, Dr. Barnett believed the tumor was what's called a glioma. A glioma is a tumor that arises in the brain's glial cells (astrocytes and oligodendrocytes), whose function is to create supporting structures for neurons, or nerve cells. Cancers are usually graded from I to IV based on how nasty they look under the microscope. He speculated mine was a grade III glioma made up of a mix of both forms of glial cells. This was one step from the summit on the glioma malignancy scale, the summit being the more common variety known as glioblastoma multiforme, or GBM. I pressed Dr. Barnett as to what his diagnosis would mean for my future. His answer was sobering: with a full course of treatment, including surgery and radiation and possibly follow-up chemotherapy, I might have one or two good years, maybe more; with surgery alone, it would be less. In either case, the outcome would be improved if he was able to remove the entire tumor. But that was the rub, and a big one. The tumor was in an unlucky location: on the left side of my brain.

Like most people, I'm "left-brained," as evidenced by my right-handedness. If I had to have a brain tumor, I knew from my basic medical training that having it on my dominant side was not the best news. The situation was even dicier because the mass sat near the brain's speech center. Speech, like handwriting, can be dominated by the left or right side of the brain, or controlled by both. (You have heard of ambidextrous people. There are also some whose speech is "ambi.") If by some stroke of good fortune my speech center happened to be located on the right side of my brain, or present in both brain hemispheres, the risk that removing the tumor could damage my ability to speak would be eliminated. So, prior to surgery, I would have a special test to determine something most of us never need to know -- exactly where all my chatter was coming from.

But figuring this out was not so easy, as I was soon to discover. It required an invasive procedure that would delay surgery for a couple of days. The procedure was very similar to a coronary catheterization -- it was even done in a cath lab -- except that the catheter was threaded into the carotid arteries that feed the brain rather than into the coronary arteries that feed the heart. Called the Wada test, after the Japanese neurologist Juhn Wada, this clever study sorts out the activities of the right and left parts of the brain by selectively putting one or the other hemisphere to sleep with a slug of short-acting phenobarbital.

The radiologist started off with my left carotid artery. As my left brain went to sleep, I instantly went mute. I was awake, alert, focused, and trying very hard as he asked me repeated questions. The words lined up in my head, wanting to be released, but instead just piled on top of one another like a nasty car wreck, at first one sentence at a time and then full paragraphs. I simply could not get them out. I suddenly felt the frustration that I have seen in the eyes of stroke victims who -- despite the fact that they see and hear, feel and reason -- are fated to keep that all locked up inside their head. It did not escape me that in a matter of a few days I had gone from being a healthy person to one experiencing a cancer, the likes of a cardiac catheterization, and the sensibility, however brief, of a major stroke.

As for me and Wada, I flunked the test, at least as I hoped it would turn out, so much so that the radiologist saw no value in even finishing the study of the other side. My speech center was located near the tumor, making the operation that much more difficult for Dr. Barnett -- and yes, for me, too. One thing was now clear in my mind: however much time I had ahead of me, I did not want to wake up from surgery unable to say thank you or communicate any other thought or feeling. My husband and I, each in our own way, relieved Dr. Barnett of any urge to be heroic with his scalpel; that is, we preferred he err on the conservative side of how much he could remove safely. As Fred put it most simply and plainly: "I want my wife back."

There was a lot to do before surgery. I had to convince Marie that the tiff we had had the night I fell ill had nothing whatsoever to do with causing my sudden visit to the ER. It turned out that I was more successful doing that than at convincing our college sophomore, Bartlett, that brain surgery wasn't such a big deal. Seyhan Soylu, Marie's godmother and a close friend to both Fred and me, dropped her work in Columbus and moved into the guest room for a week, shoring us all up with her warm and quiet strength.

I also had to put my professional life in order. I took on the task of canceling my appointments at the medical school for the next four weeks, meetings that no longer seemed so earth-shatteringly important. Those that were, I'd do by phone. "No problem; don't yet know for sure what it is; a little brain surgery and I'll be back in a few weeks." I listened to myself repeating these facts strongly and confidently, when I felt so weak and wimpy. But clear-voiced and confident was for me the way to go; wearing my fears on my sleeve only made them scarier. One of the axioms I live by is never scare the children -- including the one inside you.

With the outcome of the Wada test in hand, Dr. Barnett gave me the option of being awake during the portion of the neurosurgery in which the tumor was actually being removed. I jumped at the idea of being awake with a purpose -- being a sentinel for my own speech center. By speaking aloud on the operating table, I would assure Dr. Barnett that his cutting was staying away from my speech zone. I've done a ton of public speaking in my time, but this recitation would become the most important speech of my life.

The operation began like all others, as Dr. Zeyd Ebrahim, theneuro-anesthesiologist, let me peacefully doze off while trying to count to ten. This gentle sleep was abruptly broken when he brought me back to full consciousness in the midst of the operation.

My face peered out from under the large green drapes. Behind me I could hear Gene Barnett's soft voice and the ever-present sucking sounds of the OR. More important, I could speak, feel my body, and wiggle my fingers and toes, though I was clearly harnessed to the operating table, with my head immobilized by some kind of paraphernalia.

I had no pain, mental or physical. Dr. Barnett had alreadynumbed my scalp with a local anesthetic and opened up a four to five-inch window into the left side of my skull to expose the tumor.

I discovered all too personally what I had learned long ago in medical school from lectures about the legendary Harvard neurosurgeon Harvey Cushing: the mind can suffer mightily, but the brain itself is incapable of feeling pain, even if tugged, cut, or singed. Cushing was famous for doing brain operations on people who were wide awake.

My brief reverie was interrupted when neurologist Hans Luders, an expert on brain geography, appeared before me in full surgical garb. How strange it was to see him there. The last time I'd spoken with him, we'd been talking about nerve cells he had been able to grow successfully in a culture. He now stood over me holding my neurosurgical homework -- a literary passage I was to read again and again during the operation. This was strangely satisfying: I was part of the team, aware of what was going on, able to influence my ownoutcome, never entirely relinquishing whatever meager control over my fate I could muster.

Like a third grader reading aloud in front of the class, I tried to pronounce each word perfectly, though the words seemed odd. I asked Dr. Luders if this passage made a lot of sense to him, and he laughed. To me, it seemed out of context and very flowery, not at all a passage that I would have chosen for this critical moment in my life. But, hey, who was I to be choosy? Just as I was feeling comfortable about my ability to handle this strange experience, Dr. Barnett told me he was finishing up and all was well. Hans made an exit, and Dr. Ebrahim put me back to sleep. The next awakening was to my smiling husband, daughter Bartlett, and dear friend Seyhan. Dr. Barnett had removed about half of the tumor and had plenty of tissue for further studies, including some newer genetic analyses that were just beginning to identify differences among subtypes of gliomas.

While in the hospital I had my first meeting with another member of my slowly assembling tumor team, a group that I soon affectionately called my brain trust. The pediatric neuro-oncologist Bruce Cohen, who happened to have a lot of experience with gliomas in both children and adults, came by to see me. A softspoken, scholarly man in his forties, he had a wise rabbinical way about him. It was easy to share my thoughts with him -- my hopes about being there for Marie's last year in middle school, and for Bartlett's college graduation in two years. We talked philosophically about those joyous life events that we all share yet are so personal to each individual. I mentioned my husband's greenhouse, whereamidst his many orchids he created an intensive-care unit forseedlings and newly grafted trees. I wanted to see those trees grow strong and tall in the outdoors. I had dreams of seeing my daughters find their right mates, and maybe even become parents themselves. My stepdaughter, Alison, had just had little Wyatt, and Fred and I had all sorts of plans for him. I was also fully expecting to see Nonie turn one hundred; to see Michele become a grandmother; and to seeMom, the family seamstress, make the christening gown.

Perhaps that was too much to hope for right then, but thesewere no idle thoughts, and Dr. Cohen knew it. I wished to remain the wife and mom my family knew, and that meant a return to my everyday professional life as well. I had just made a great effort to protect my speech center, and I was no less dedicated to the preservation of my brain. I have always been driven by brain, not brawn, and I wanted Dr. Cohen to know exactly what this meant to me.

It was too early to discuss the specifics of my subsequent course of treatment with him while the tumor was still being analyzed in the laboratory, but this preliminary conversation was critical to laying out just how I felt about what I expected from therapy. I already knew that radiating the brain was the conventional and nearuniversal approach; chemotherapies were deemed second string and usually ineffective. I confessed to a bias against brain radiation; it was easy on the rest of the body but invariably damaged at least some healthy brain tissue. Though the kinds of chemo that were in use or on the experimental horizon were rough on the rest of the body, they spared the brain. Dr. Cohen was sympathetic to my personal thinking on this but gently warned me that chemo alone would be seen as "malpractice" by at least some of the experts in the field.

When we received the pathology studies several days later there was some good news. My tumor was of the less common variety, called an oligodendroglioma (as opposed to the more common astrocytoma),a rather obscure tumor that was just starting to make a splash because of its unusual genetics. Dr. Cohen gave me a brief tutorial on work currently being done in Canada at the University of Toronto, where recent studies suggested that at least one subtype of this tumor, when it carried a particular genetic profile, was surprisingly responsive to therapy -- including chemo. He did not want to get my hopes up, but he said Dr. Barnett was to perform genetic tests on my tumor, with results in a few weeks. If it fit a particular gene profile called a 1p-19q deletion (in which hunks of chromosomes 1 and 19 are missing), there was an increased chance that I might havean enduring response from chemotherapy and that radiation could be forestalled, if not avoided entirely.

He cautioned me again, however, that opting for chemotherapyalone was not standard care, or, in today's parlance, "evidencebased" care. Instead, what he described to me was in essence the emerging strategy now known as targeted treatment -- I'll discuss that in detail later -- in which therapy is tailored to match a given person's tumor genetics and to his or her personal life choices.

There were no conclusions reached that day -- it was only twodays after my operation -- but this meeting set the stage for many decisions that would be made in the weeks and years ahead. I fervently believe that this kind of straight and personal talk is one that cancer patients must have with their doctors early on. Though one needs the guidance and perspective of the doctors -- I later met with several other doctors who had their own views and would become part of my medical team -- never for a moment did Fred or I lose sight of the fact that we were the ones who would live with whatever choices were made. And that's true for every patient.

Before I left the hospital, Dr. Barnett stopped by to unwrap my head bandages. For the first time I realized I still had most of my hair. I never thought to ask about it before surgery, but there it was covering up that long incision and making me feel quite unchanged. In fact, it gave me a little jolt of confidence as I went home to face the next phase of fighting this cancer, diminished but still there.

Excerpted from Living Time by Bernadine Healy Copyright © 2007 by Bernadine Healy . Excerpted by permission of Bantam, a division of Random House Inc. All rights reserved. No part of this excerpt may be reproduced or reprinted without permission in writing from the publisher.